Literature DB >> 30209078

Mcp1 Promotes Macrophage-Dependent Cyst Expansion in Autosomal Dominant Polycystic Kidney Disease.

Marcelo F Cassini1, Vijayakumar R Kakade1, Elizabeth Kurtz1, Parker Sulkowski2,3, Peter Glazer2,3, Richard Torres4, Stefan Somlo1, Lloyd G Cantley5.   

Abstract

BACKGROUND: In patients with autosomal dominant polycystic kidney disease (ADPKD), most of whom have a mutation in PKD1 or PKD2, abnormally large numbers of macrophages accumulate around kidney cysts and promote their growth. Research by us and others has suggested that monocyte chemoattractant protein-1 (Mcp1) may be a signal for macrophage-mediated cyst growth.
METHODS: To define the role of Mcp1 and macrophages in promoting cyst growth, we used mice with inducible knockout of Pkd1 alone (single knockout) or knockout of both Pkd1 and Mcp1 (double knockout) in the murine renal tubule. Levels of Mcp1 RNA expression were measured in single-knockout mice and controls.
RESULTS: In single-knockout mice, upregulation of Mcp1 precedes macrophage infiltration. Macrophages accumulating around nascent cysts (0-2 weeks after induction) are initially proinflammatory and induce tubular cell injury with morphologic flattening, oxidative DNA damage, and proliferation-independent cystic dilation. At 2-6 weeks after induction, macrophages switch to an alternative activation phenotype and promote further cyst growth because of an additional three-fold increase in tubular cell proliferative rates. In double-knockout mice, there is a marked reduction in Mcp1 expression and macrophage numbers, resulting in less initial tubular cell injury, slower cyst growth, and improved renal function. Treatment of single-knockout mice with an inhibitor to the Mcp1 receptor Ccr2 partially reproduced the morphologic and functional improvement seen with Mcp1 knockout.
CONCLUSIONS: Mcp1 is upregulated after knockout of Pkd1 and promotes macrophage accumulation and cyst growth via both proliferation-independent and proliferation-dependent mechanisms in this orthologous mouse model of ADPKD.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  ADPKD; Immunology and pathology; MCP-1; genetic renal disease; kidney tubule; polycystic kidney disease

Mesh:

Substances:

Year:  2018        PMID: 30209078      PMCID: PMC6171277          DOI: 10.1681/ASN.2018050518

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  39 in total

1.  Distinct macrophage phenotypes contribute to kidney injury and repair.

Authors:  Sik Lee; Sarah Huen; Hitoshi Nishio; Saori Nishio; Heung Kyu Lee; Bum-Soon Choi; Christiana Ruhrberg; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2011-02       Impact factor: 10.121

2.  Oxidative and nitrosative stress in acute renal ischemia.

Authors:  E Noiri; A Nakao; K Uchida; H Tsukahara; M Ohno; T Fujita; S Brodsky; M S Goligorsky
Journal:  Am J Physiol Renal Physiol       Date:  2001-11

3.  Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease.

Authors:  Li Chen; Xia Zhou; Lucy X Fan; Ying Yao; Katherine I Swenson-Fields; Mihaela Gadjeva; Darren P Wallace; Dorien J M Peters; Alan Yu; Jared J Grantham; Xiaogang Li
Journal:  J Clin Invest       Date:  2015-05-11       Impact factor: 14.808

4.  GM-CSF Promotes Macrophage Alternative Activation after Renal Ischemia/Reperfusion Injury.

Authors:  Sarah C Huen; Larry Huynh; Arnaud Marlier; Yashang Lee; Gilbert W Moeckel; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2014-11-11       Impact factor: 10.121

5.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

6.  The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury.

Authors:  Li Li; Liping Huang; Sun-Sang J Sung; Amy L Vergis; Diane L Rosin; C Edward Rose; Peter I Lobo; Mark D Okusa
Journal:  Kidney Int       Date:  2008-10-08       Impact factor: 10.612

7.  Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.

Authors:  Richard Torres; Heino Velazquez; John J Chang; Michael J Levene; Gilbert Moeckel; Gary V Desir; Robert Safirstein
Journal:  J Am Soc Nephrol       Date:  2015-08-24       Impact factor: 10.121

8.  A tumor necrosis factor-alpha-mediated pathway promoting autosomal dominant polycystic kidney disease.

Authors:  Xiaogang Li; Brenda S Magenheimer; Sheng Xia; Teri Johnson; Darren P Wallace; James P Calvet; Rong Li
Journal:  Nat Med       Date:  2008-06-15       Impact factor: 53.440

9.  Oxidative damage in multiple sclerosis lesions.

Authors:  Lukas Haider; Marie T Fischer; Josa M Frischer; Jan Bauer; Romana Höftberger; Gergö Botond; Harald Esterbauer; Christoph J Binder; Joseph L Witztum; Hans Lassmann
Journal:  Brain       Date:  2011-06-07       Impact factor: 13.501

10.  Tolvaptan suppresses monocyte chemotactic protein-1 excretion in autosomal-dominant polycystic kidney disease.

Authors:  Jared J Grantham; Arlene B Chapman; Jaime Blais; Frank S Czerwiec; Olivier Devuyst; Ron T Gansevoort; Eiji Higashihara; Holly Krasa; Wen Zhou; John Ouyang; Ronald D Perrone; Vicente E Torres
Journal:  Nephrol Dial Transplant       Date:  2017-06-01       Impact factor: 5.992

View more
  38 in total

Review 1.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

Review 2.  Role of chemokines, innate and adaptive immunity.

Authors:  Kurt A Zimmerman; Katharina Hopp; Michal Mrug
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

3.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

4.  Are Cyst-Associated Macrophages in Polycystic Kidney Disease the Equivalent to TAMs in Cancer?

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2018-09-12       Impact factor: 10.121

5.  Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis.

Authors:  Bo Yang; Lili Fu; Jamie R Privratsky; Xiaohan Lu; Jiafa Ren; Changlin Mei; Steven D Crowley
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-29

6.  Role of cyclin-dependent kinase 2 in the progression of mouse juvenile cystic kidney disease.

Authors:  Jennifer Qin Jing Zhang; Jane Burgess; Daria Stepanova; Sayanthooran Saravanabavan; Annette T Y Wong; Philipp Kaldis; Gopala K Rangan
Journal:  Lab Invest       Date:  2020-01-08       Impact factor: 5.662

Review 7.  It Takes Two to Tango: The Role of Dysregulated Metabolism and Inflammation in Kidney Disease Development.

Authors:  Ghazal Z Quinn; Poonam Dhillon; Katalin Susztak
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 8.  The Controversial Role of Fibrosis in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Maria Fragiadaki; Fiona M Macleod; Albert C M Ong
Journal:  Int J Mol Sci       Date:  2020-11-25       Impact factor: 5.923

Review 9.  Progress in the understanding of polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Nat Rev Nephrol       Date:  2019-02       Impact factor: 28.314

10.  Rapamycin and dexamethasone during pregnancy prevent tuberous sclerosis complex-associated cystic kidney disease.

Authors:  Morris Nechama; Yaniv Makayes; Elad Resnick; Karen Meir; Oded Volovelsky
Journal:  JCI Insight       Date:  2020-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.